Literature DB >> 23508011

Prevalence of a new auto-activating colony stimulating factor 3 receptor mutation (CSF3R-T595I) in acute myeloid leukemia and severe congenital neutropenia.

Renée Beekman, Marijke Valkhof, Paulette van Strien, Peter J M Valk, Ivo P Touw.   

Abstract

Entities:  

Keywords:  acute myeloid leukemia; colony stimulating factor 3 receptor mutation; severe congenital neutropenia

Mesh：

Substances：

Year:  2013        PMID： 23508011      PMCID： PMC3640133          DOI： 10.3324/haematol.2013.085050

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia.

Authors:  Renée Beekman; Marijke G Valkhof; Mathijs A Sanders; Paulette M H van Strien; Jurgen R Haanstra; Lianne Broeders; Wendy M Geertsma-Kleinekoort; Anjo J P Veerman; Peter J M Valk; Roel G Verhaak; Bob Löwenberg; Ivo P Touw
Journal:  Blood       Date:  2012-02-27       Impact factor: 22.113

2.  G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth.

Authors:  Quan-Sheng Zhu; Ling Xia; Gordon B Mills; Clifford A Lowell; Ivo P Touw; Seth J Corey
Journal:  Blood       Date:  2005-11-10       Impact factor: 22.113

3.  Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey.

Authors:  Manuela Germeshausen; Matthias Ballmaier; Karl Welte
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

4.  Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.

Authors:  F Dong; D C Dale; M A Bonilla; M Freedman; A Fasth; H J Neijens; J Palmblad; G L Briars; G Carlsson; A J Veerman; K Welte; B Löwenberg; I P Touw
Journal:  Leukemia       Date:  1997-01       Impact factor: 11.528

Review 5.  Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders.

Authors:  Ivo P Touw; Gert-Jan M van de Geijn
Journal:  Front Biosci       Date:  2007-01-01

6.  A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.

Authors:  D C Dale; M A Bonilla; M W Davis; A M Nakanishi; W P Hammond; J Kurtzberg; W Wang; A Jakubowski; E Winton; P Lalezari
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

7.  An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia.

Authors:  Louisa V Forbes; Rosemary E Gale; Arnold Pizzey; Karin Pouwels; Amit Nathwani; David C Linch
Journal:  Oncogene       Date:  2002-09-05       Impact factor: 9.867

8.  Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia.

Authors:  Daniel C Link; Ghada Kunter; Yumi Kasai; Yu Zhao; Tracie Miner; Michael D McLellan; Rhonda E Ries; Deepak Kapur; Rakesh Nagarajan; David C Dale; Audrey Anna Bolyard; Laurence A Boxer; Karl Welte; Cornelia Zeidler; Jean Donadieu; Christine Bellanné-Chantelot; James W Vardiman; Michael A Caligiuri; Clara D Bloomfield; John F DiPersio; Michael H Tomasson; Timothy A Graubert; Peter Westervelt; Mark Watson; William Shannon; Jack Baty; Elaine R Mardis; Richard K Wilson; Timothy J Ley
Journal:  Blood       Date:  2007-05-09       Impact factor: 22.113

9.  Suppressor of cytokine signaling 3 controls lysosomal routing of G-CSF receptor.

Authors:  Mahban I Irandoust; Lambertus H J Aarts; Onno Roovers; Judith Gits; Stefan J Erkeland; Ivo P Touw
Journal:  EMBO J       Date:  2007-03-15       Impact factor: 11.598

10.  A point mutation in the granulocyte colony-stimulating factor receptor (G-CSF-R) gene in a case of acute myeloid leukemia results in the overexpression of a novel G-CSF-R isoform.

Authors:  F Dong; M van Paassen; C van Buitenen; L H Hoefsloot; B Löwenberg; I P Touw
Journal:  Blood       Date:  1995-02-15       Impact factor: 22.113
View more
  14 in total

1.  Severe congenital neutropenia and chronic neutrophilic leukemia: an intriguing molecular connection unveiled by oncogenic mutations in CSF3R.

Authors:  Ivo P Touw; Renée Beekman
Journal:  Haematologica       Date:  2013-10       Impact factor: 9.941

2.  Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization.

Authors:  Julia E Maxson; Samuel B Luty; Jason D MacManiman; Melissa L Abel; Brian J Druker; Jeffrey W Tyner
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

3.  The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.

Authors:  Julia E Maxson; Samuel B Luty; Jason D MacManiman; Jason C Paik; Jason Gotlib; Peter Greenberg; Swaleh Bahamadi; Samantha L Savage; Melissa L Abel; Christopher A Eide; Marc M Loriaux; Emily A Stevens; Jeffrey W Tyner
Journal:  Clin Cancer Res       Date:  2015-10-16       Impact factor: 12.531

4.  CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML.

Authors:  Julia E Maxson; Rhonda E Ries; Yi-Cheng Wang; Robert B Gerbing; E Anders Kolb; Sarah L Thompson; Jaime M Guidry Auvil; Marco A Marra; Yussanne Ma; Zusheng Zong; Andrew J Mungall; Richard Moore; William Long; Patee Gesuwan; Tanja M Davidsen; Leandro C Hermida; Seamus B Hughes; Jason E Farrar; Jerald P Radich; Malcolm A Smith; Daniela S Gerhard; Alan S Gamis; Todd A Alonzo; Soheil Meshinchi
Journal:  Blood       Date:  2016-05-03       Impact factor: 22.113

Review 5.  An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms.

Authors:  A Tefferi; J Thiele; A M Vannucchi; T Barbui
Journal:  Leukemia       Date:  2014-01-20       Impact factor: 11.528

Review 6.  Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies.

Authors:  Pankaj Dwivedi; Kenneth D Greis
Journal:  Exp Hematol       Date:  2016-10-24       Impact factor: 3.084

Review 7.  Genomics of chronic neutrophilic leukemia.

Authors:  Julia E Maxson; Jeffrey W Tyner
Journal:  Blood       Date:  2016-12-27       Impact factor: 22.113

8.  CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.

Authors:  A Pardanani; T L Lasho; R R Laborde; M Elliott; C A Hanson; R A Knudson; R P Ketterling; J E Maxson; J W Tyner; A Tefferi
Journal:  Leukemia       Date:  2013-04-22       Impact factor: 11.528

9.  A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia.

Authors:  David R Spiciarich; Stephen T Oh; Amy Foley; Seamus B Hughes; Michael J Mauro; Omar Abdel-Wahab; Richard D Press; Rosa Viner; Sarah L Thompson; Qiushi Chen; Parastoo Azadi; Carolyn R Bertozzi; Julia E Maxson
Journal:  Cancer Res       Date:  2018-10-22       Impact factor: 12.701

Review 10.  Granulocyte colony-stimulating factor receptor mutations in myeloid malignancy.

Authors:  Clifford Liongue; Alister Curtis Ward
Journal:  Front Oncol       Date:  2014-05-01       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.